Extra Trump offers to decrease drug costs : Pictures

[ad_1] <img src="https://npr.brightspotcdn.com/dims3/default/strip/false/crop/8256x5504+0+0/resize/1100/quality/50/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F1c%2F74%2F632bdc6d4d198f7639342dcf73bd%2Fgettyimages-2252073612.jpg" data-template="https://npr.brightspotcdn.com/dims3/default/strip/false/crop/8256x5504+0+0/resize/{width}/quality/{quality}/format/{format}/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F1c%2F74%2F632bdc6d4d198f7639342dcf73bd%2Fgettyimages-2252073612.jpg" class="img" alt="President Trump unveiled deals with nine pharmaceutical companies on drug prices in a White House event Friday in Washington, DC, on December 19, 2025. (Photo by Brendan SMIALOWSKI / AFP via Getty Images)" fetchpriority="high"/> President Trump unveiled offers with 9 pharmaceutical corporations on drug costs in a White Home occasion Friday. BRENDAN SMIALOWSKI/AFP through Getty Photographs cover caption

toggle caption

BRENDAN SMIALOWSKI/AFP through Getty Photographs President Trump mentioned the administration has reached agreements with 9 extra drugmakers to convey their U.S. drug costs extra in step with what different rich nations pay.

Fourteen corporations in complete have now reached what the administration calls most-favored-nation pricing offers. The businesses that took half in Friday's announcement have been: Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi.

They agreed to cost the U.S. authorities no extra for brand new medicine than the costs paid by different well-off nations. The agreements will enable state Medicaid packages to entry decrease costs from the 9 corporations. In a press release, the White Home mentioned the change will end result "in billions of {dollars} in financial savings."

The drugmakers additionally agreed to speculate no less than $150 billion in manufacturing operations within the U.S. The president is looking for to extend home manufacturing of prescription drugs.

As well as, the businesses agreed to make a few of their hottest medicine accessible at decrease costs to customers who pay out of pocket via a authorities web site known as TrumpRx.com. The TrumpRx web site is anticipated to launch in early 2026, and would take customers to pharmaceutical corporations' direct-to-consumer web sites to meet orders.

For instance, Merck will cut back the value of Januvia, a drugs for Kind 2 diabetes, from $330 to $100 for sufferers buying instantly via TrumpRx, the White Home mentioned. Amgen will cut back the value of Repatha, a cholesterol-lowering drug, from $573 to $239 when bought via TrumpRx.

In trade for these concessions, the businesses will likely be exempt from potential administration tariffs for 3 years.

The extent of financial savings for customers underneath the agreements is unclear. Medicaid and its beneficiaries already pay a few of the lowest costs for medicine. And other people with medical health insurance might spend much less on copays for his or her medicines than paying money for them via the drugmakers.

Individually, Trump mentioned through the press occasion that he want to get well being insurers to decrease their costs, too.

"I'll name a gathering of the insurance coverage corporations," he mentioned. "I'll see in the event that they [will] get their worth down, to place it very bluntly."